Novo valuation surpasses Tesla on experimental obesity drug data
08
Mar
Novo valuation surpasses Tesla on experimental obesity drug data Subject: Science and tech Section: Health Context: Novo Nordisk’s market valuation has surpassed Tesla and Visa after announcing positive early trial data for a new obesity drug; shares rose over 8% to record highs. More on news: Shares surged more than 8% to record […]